May 05, 2014 |
Atrion Reports First Quarter Results |
ALLEN, TX--(Marketwired - May 5, 2014) - Atrion Corporation (NASDAQ: ATRI) today announced diluted earnings per share for the first quarter of 2014 were up 10% to $3.61 as compared to $3.28 in the first quarter of 2013.
Atrion's revenues for the quarter ended March 31, 2014 were $36,419,000 compared with $33,493,000 in the same period in 2013. Net income in the current-year quarter totaled $7,201,000 compared to $6,635,000 in last year's first quarter.
Commenting on the Company's results for the first quarter of 2014 compared to the same period last year, David A. Battat, President & CEO, said, "We are pleased with the significant increase in revenues, with solid growth in our cardiovascular and fluid delivery product lines. Overall, compared to the same quarter last year, revenues were up 9%, operating income was up 14%, and diluted EPS increased 10%. The EPS comparisons are skewed due to Congress's persistently inconsistent timing in extending R&D tax credits. Five quarters worth of R&D tax credits had to be recorded in the first quarter of 2013, while no credits could be booked in the just finished quarter." Mr. Battat added, "During the quarter we invested $4.7 million to purchase 15,142 shares of our common stock, while continuing to be debt free as well as having $55.0 million in cash and short and long term investments at the end of the quarter."
Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com.
|
|
ATRION CORPORATION |
|
CONSOLIDATED STATEMENTS OF INCOME |
|
(In thousands, except per share data) |
|
(Unaudited) |
|
|
|
|
|
Three Months Ended
March 31, |
|
|
|
2014 |
|
|
2013 |
|
Revenues |
|
$ |
36,419 |
|
|
$ |
33,493 |
|
Cost of goods sold |
|
|
19,031 |
|
|
|
17,784 |
|
|
Gross profit |
|
|
17,388 |
|
|
|
15,709 |
|
Operating expenses |
|
|
6,688 |
|
|
|
6,309 |
|
|
Operating income |
|
|
10,700 |
|
|
|
9,400 |
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
300 |
|
|
|
350 |
|
Other income (expense), net |
|
|
1 |
|
|
|
-- |
|
|
Income before income taxes |
|
|
11,001 |
|
|
|
9,750 |
|
Income tax provision |
|
|
(3,800 |
) |
|
|
(3,115 |
) |
|
Net income |
|
|
7,201 |
|
|
|
6,635 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income per basic share |
|
$ |
3.63 |
|
|
$ |
3.28 |
|
|
|
|
|
|
|
|
|
|
Weighted average basic shares outstanding |
|
|
1,982 |
|
|
|
2,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income per diluted share |
|
$ |
3.61 |
|
|
$ |
3.28 |
|
|
|
|
|
|
|
|
|
|
Weighted average diluted shares outstanding |
|
|
1,997 |
|
|
|
2,024 | |
|
|
|
|
|
|
|
|
|
|
ATRION CORPORATION |
CONSOLIDATED BALANCE SHEETS |
(In thousands) |
|
|
|
Mar. 31, |
|
Dec. 31, |
ASSETS |
|
2014 |
|
2013 |
|
|
(Unaudited) |
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
17,196 |
|
$ |
28,559 |
|
Short-term investments |
|
|
25,417 |
|
|
18,351 |
|
|
Total cash and short-term investments |
|
|
42,613 |
|
|
46,910 |
|
Accounts receivable |
|
|
18,642 |
|
|
14,164 |
|
Inventories |
|
|
26,326 |
|
|
26,266 |
|
Prepaid expenses and other |
|
|
1,008 |
|
|
1,603 |
|
Deferred income taxes |
|
|
1,376 |
|
|
1,376 |
|
|
|
Total current assets |
|
|
89,965 |
|
|
90,319 |
|
|
|
|
|
|
|
Long-term investments |
|
|
12,375 |
|
|
10,069 |
|
|
|
|
|
|
|
Property, plant and equipment, net | |
|
59,580 |
|
|
58,328 |
Other assets |
|
|
13,280 |
|
|
13,350 |
|
|
|
|
|
|
|
|
|
$ |
175,200 |
|
$ |
172,066 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
11,636 |
|
|
9,364 |
|
Line of credit |
|
|
-- |
|
|
-- |
|
Other non-current liabilities |
|
|
12,934 |
|
|
13,708 |
|
Stockholders' equity |
|
|
150,630 |
|
|
148,994 |
|
|
|
|
|
|
|
|
|
$ |
175,200 |
|
$ |
172,066 |
|
|
|
|
|
|
|
|
|